A comprehensive guide to the biology of Ebola, the structural conditions driving repeated outbreaks, the institutional record of WHO and African governments, the question of racial inequity in global health response, and what lasting solutions require.
What
This Article Explains
This article addresses five connected issues: how the Ebola virus
spreads and why it is lethal; why it repeatedly re-emerges in Central and West
Africa; how weak health systems, conflict, and poverty amplify every outbreak;
why access to vaccines and treatments remains deeply unequal across the world;
and what African governments, the WHO, international donors, and the research
community must do differently if the cycle is ever to end.
Introduction
On 17 May 2026, the World Health Organization
declared the Ebola disease outbreak caused by Bundibugyo virus in the
Democratic Republic of the Congo and Uganda a Public Health Emergency of
International Concern. It was not a surprise. It was the seventeenth recorded
Ebola outbreak in the DRC since the virus was first identified in 1976. The
previous DRC outbreak had ended just five months earlier, in December 2025.
The question the world should be asking is not
whether Ebola will return. It already has. The question is why, after half a
century of outbreaks, scientific knowledge, and institutional responses,
humanity remains unable to break the cycle — and whether the persistent lack of
urgency from wealthy Western nations reflects something more troubling than
bureaucratic failure.
This article examines Ebola from the ground up: the biology that makes it dangerous, the structural conditions that allow it to persist, the record of the WHO and African governments, the role of funding inequality in shaping global health outcomes, and what a serious long-term solution would genuinely require.
|
LATEST UPDATE — 15 June 2026 As of 13 to 14 June 2026, the DRC Ministry of Health has reported 782
confirmed cases and 181 confirmed deaths across three provinces, with 359
individuals hospitalised in isolation. Ituri Province remains the most
affected area, with 717 confirmed cases across 20 health zones. Uganda has
reported 19 confirmed cases and 2 confirmed deaths from imported cases. WHO
and Africa CDC launched a joint continental preparedness and response plan on
5 June 2026. These figures should be treated as provisional because responders
have reported data gaps, delayed testing, undercounted community deaths and
possible duplicate counting across health zones. This is a developing
emergency. Readers should consult WHO, Africa CDC, and national health
authorities for the most current operational updates. |
Understanding
Ebola: The Science of a Dangerous Virus
What
Ebola Is and How It Causes Disease
Ebola virus disease is caused by viruses belonging
to the genus Orthoebolavirus, a family of RNA viruses responsible for severe
haemorrhagic fever in humans and other primates. Four species cause disease in
humans: Zaire ebolavirus, Sudan ebolavirus, Bundibugyo ebolavirus, and Taï
Forest ebolavirus. Each has distinct characteristics, geographic patterns, and
different responses to available medical countermeasures.
The virus spreads through direct contact with the
blood, secretions, organs, or other bodily fluids of infected people or
animals. It does not spread through the air under normal conditions. This is an
important distinction: Ebola cannot be transmitted by casual contact, breathing
shared air, or touching contaminated surfaces in the way respiratory viruses
such as influenza or COVID-19 can. Despite this, it has caused devastating
outbreaks because of how aggressively it attacks the body and because of the environments
in which it typically emerges.
Symptoms begin suddenly, typically between two and
twenty-one days after infection. Initial signs — fever, fatigue, muscle pain,
headache, and sore throat — can resemble malaria, typhoid, or meningitis,
making early clinical diagnosis difficult. As the disease progresses, vomiting,
diarrhoea, rash, and impaired kidney and liver function develop. In severe
cases, internal and external bleeding occur. The virus disrupts the body's
clotting mechanism and overwhelms the immune system, leading to multi-organ failure.
Survivors of Ebola face serious long-term health challenges, including joint
pain, eye problems, and in some cases prolonged viral persistence in certain
body fluids, which has been linked to survivor-associated transmission in
previous outbreaks.
|
Key
Clinical Fact Case fatality rates in Ebola outbreaks have historically ranged from
25 to 90 per cent. Based on reported confirmed cases and deaths in mid-June
2026, the crude confirmed case fatality rate was around 23 per cent, although
this figure may change as delayed reporting, testing backlogs, recoveries and
undercounted community deaths are clarified. Previous Bundibugyo outbreaks
had fatality rates of 30 to 50 per cent; the current figure may reflect
improved clinical care protocols and earlier supportive treatment in some
facilities. No licensed vaccine or specific therapeutic exists for the
Bundibugyo strain. |
Ebola
and Marburg: Related but Different
Ebola and Marburg virus disease are often discussed
together because both belong to the Filoviridae family and cause similar
haemorrhagic fevers. However, they are distinct viruses with different
geographic origins, reservoir species, and outbreak patterns. Marburg virus is
associated with the Egyptian fruit bat (Rousettus aegyptiacus) as a confirmed
reservoir and has caused outbreaks primarily in East and Central Africa, most
recently in Rwanda in 2024. Ebola's primary reservoir is believed to involve fruit
bats, but the specific species and ecological dynamics differ by Ebola strain.
Neither virus has a widely available approved vaccine, and both illustrate the
same systemic failure: lethal filoviruses circulating in African populations
for decades without adequate countermeasures being developed or deployed.
The
Animal Reservoir: Why Ebola Persists in Nature
The most important and still incompletely
understood feature of Ebola is its persistence between human outbreaks. The
virus does not disappear when an outbreak ends. It survives in an animal
reservoir — most likely fruit bat species — which carry the virus without
developing disease. Humans become infected through direct or indirect contact
with infected animals, typically during hunting, butchering, or consuming
bushmeat.
Research published in CDC's Emerging Infectious
Diseases journal in 2025 confirmed that zoonotic spillover of Ebolavirus
species into humans occurs approximately once per year on average, driven in
large part by ecological disruption: deforestation, mining expansion, and human
encroachment into forested habitats bring communities into closer contact with
wildlife hosts. It is important to note, however, that the precise reservoir
ecology remains a subject of active investigation. Scientists have not confirmed
which specific bat species carry which Ebola strains, and some researchers
believe additional reservoir hosts may be involved.
A 2026 preprint study employing novel phylogenetic
modelling found that the prevailing scientific model of Ebola reservoir
dynamics is deficient, and that the long-term evolutionary rate of the virus
appears slower than previously believed. This matters because it suggests that
conventional outbreak models based on earlier assumptions may need revision,
and that viral persistence between outbreaks may be more complex than
previously thought.
Until the reservoir is better characterised and the
ecological conditions driving spillover are addressed at source, Ebola will
continue to re-emerge. No amount of outbreak response can prevent the next
spillover event if the conditions creating spillover remain unchanged.
Why
Ebola Keeps Coming Back: Structural Drivers of Repeated Outbreaks
Poverty,
Conflict, and the Absence of Functioning Health Infrastructure
Ebola does not return repeatedly to countries with
well-funded health systems and effective emergency response capacity. It
returns to places where infrastructure has been hollowed out by generations of
underfunding, colonial extraction, post-colonial neglect, and persistent armed
conflict. The 2026 Bundibugyo outbreak in the DRC's Ituri Province illustrates
this pattern with stark clarity.
WHO's own assessment confirmed that conflict, poor
infrastructure, and insecurity were limiting the movement of aid and access to
health services in the affected area, and that many health facilities were
either non-functional or operating under severe constraints. Nearly 10 million
people across four affected eastern provinces were facing acute food insecurity
between January and June 2026. Hunger compounds vulnerability to infection:
malnourished populations have weaker immune responses, and communities experiencing
acute food insecurity are less able to maintain the safe practices that limit
transmission.
This is the seventeenth Ebola outbreak in the DRC
in fifty years. The pattern is not coincidental. Eastern DRC is a region of
extraordinary mineral wealth, chronic armed conflict, and systematic
underdevelopment. Healthcare workers there do not lack professionalism or
dedication. They lack the roads, laboratories, hospitals, supply chains, and
staffing levels that comparable health systems in wealthier countries consider
baseline requirements.
Community
Distrust and the Legacy of Exploitation
A less discussed but equally powerful driver of
Ebola's persistence is the deep distrust of outside authorities that
characterises many of the communities most affected. Analysts at the Council on
Foreign Relations, examining the 2026 DRC outbreak, noted that generations of
exploitation had created a backdrop of profound mistrust that made every aspect
of the response significantly harder.
This distrust is historically grounded rather than
irrational. Communities in eastern DRC have endured Belgian colonial
extraction, post-independence political violence, decades of exploitation by
multinational mining interests with minimal local benefit, and successive waves
of humanitarian intervention that left little lasting improvement in daily
life. When health workers arrive in protective equipment to take bodies and
instruct communities to abandon burial practices carrying deep cultural and
spiritual significance, resistance is understandable.
Safe and dignified burials, community health
workers drawn from and accountable to local populations, and sustained
investment in community trust-building are among the most effective
interventions in Ebola response. They are also chronically underfunded compared
with the technical and clinical elements of outbreak management.
Ecology,
Deforestation, and Climate
The ecological conditions driving zoonotic
spillover are deteriorating across the region. Forest loss in Central and West
Africa continues to narrow the buffer between human settlements and the
wildlife populations that carry filoviruses. Agricultural expansion, artisanal
mining, and infrastructure projects push communities deeper into forested
areas. Climate variability alters the movement patterns and population dynamics
of reservoir species, creating contact opportunities that standard public
health surveillance has not been designed to detect.
Addressing these drivers requires integrating
environmental management, alternative livelihood programmes, and wildlife
surveillance into Africa's development planning. They cannot be treated as
peripheral to public health. They are its upstream determinants.
What
the WHO Has Done: Achievements and Documented Failures
The
Record of Response
The World Health Organization has, over five
decades, developed real expertise in Ebola outbreak response. It coordinates
international response efforts, provides technical support on surveillance,
contact tracing, infection prevention, and laboratory confirmation, and governs
declarations of Public Health Emergencies of International Concern through
which international obligations are triggered.
During the 2018 to 2020 outbreak in DRC's North
Kivu Province — one of the most complex in history, unfolding in an active
conflict zone — WHO-coordinated ring vaccination with the rVSV-ZEBOV vaccine
reached over 300,000 people and ultimately helped bring the outbreak under
control. In May 2026, WHO moved within days of confirmed case identification to
declare a Public Health Emergency and convene its Emergency Committee, and has
coordinated the launch of a joint continental response plan with Africa CDC.
Where
the WHO Has Failed
Against this record, the WHO's documented failures
in Ebola response are serious and have been acknowledged at the highest
institutional levels.
The most consequential failure occurred during the
2014 to 2016 West Africa epidemic, which ultimately killed more than eleven
thousand people. An internal WHO document obtained by the Associated Press
found that nearly everyone involved in the outbreak response failed to see some
fairly plain writing on the wall. The report identified incompetent staff,
bureaucratic obstruction, politically motivated country office appointments,
and an institutional failure to recognise that standard containment strategies
would not work in a region with porous borders and broken health systems.
Bureaucratic hurdles prevented emergency funds from reaching the response
effort in Guinea, and doctors were unable to gain access because visas had not
been secured.
Independent expert panels reached the same
conclusions. WHO was accused of failing to react swiftly, of incompetent
handling, and of underestimating the scale of the crisis until it was
catastrophically large.
Subsequent reforms have produced incremental
improvements, including the creation of WHO's Health Emergencies Programme in
2016. However, structural vulnerabilities remain. WHO is dependent on voluntary
contributions from member states who can restrict how funds are used. Its
authority over sovereign governments is advisory rather than binding. And its
decision-making is subject to political pressures that can delay action when
powerful economies perceive outbreak declarations as threats to trade and travel.
|
Critical
Funding Loss The withdrawal of US funding from WHO in 2025 prompted staff
reductions that no other donor nation moved to fill. Former USAID officials
confirmed that experienced outbreak response teams with established local
relationships were lost when the agency was dismantled. Africa CDC reported
that official development assistance for African health dropped from
approximately 26 billion US dollars in 2021 to around 13 billion in 2025 — a
fall of more than 50 per cent in four years. |
What African Governments and Institutions Have Done
Building
a Continental Response Capacity
African governments and institutions have not been
passive in the face of repeated outbreaks. The Africa Centres for Disease
Control and Prevention, established by the African Union in 2017 following the
scale and failures of the West Africa epidemic, represents the most significant
institutional development in African public health architecture in a
generation.
Africa CDC has deployed rapid response teams across
successive outbreaks, coordinated cross-border surveillance, and worked with
national ministries of health to develop laboratory networks, surveillance
systems, and emergency preparedness frameworks. In the 2018 to 2020 DRC
outbreak, Africa CDC collaborated with WHO and national authorities to
vaccinate over 100,000 people in North Kivu and Ituri Provinces. In response to
the 2026 Bundibugyo outbreak, Africa CDC co-launched a joint continental
strategic preparedness and response plan with WHO on 5 June 2026.
It is equally important to recognise the
contribution of those who are hardest to count: the community health workers,
burial teams, nurses, laboratory technicians, contact tracers, and local
community leaders who face personal risk every time an outbreak occurs. The
response to every Ebola outbreak in Africa has been carried, in large measure,
by African people on the ground who are given inadequate resources but
demonstrate extraordinary commitment.
The
Structural Constraints That Limit Delivery
The gap between institutional ambition and
operational delivery is explained primarily by the fiscal and political
constraints within which African health ministries operate. Many national
health budgets remain structurally insufficient — partly a consequence of debt
obligations, structural adjustment programme legacies, and terms of
international lending that have historically constrained public social
spending.
The director-general of Africa CDC stated plainly
that every time an outbreak occurs, countries have to ask for partners because
they do not have in their budgets the funding to respond, let alone prepare.
This dependency is a structural problem rather than a governance failure. When
international funding flows are cut for political reasons — as occurred with
major Western donors in 2025 — African health systems absorb the consequences
with no adequate substitute.
A
Disease of Black People? Racial Inequity in the Global Health Response to Ebola
The
Pattern That Demands an Honest Answer
The question of whether Ebola has been treated by
the global health system as a crisis that becomes urgent only when it threatens
to move beyond Black African populations is uncomfortable. It is also
legitimate, and the weight of documented evidence demands a direct response
rather than diplomatic evasion.
Since 1976, every significant Ebola outbreak has
occurred in sub-Saharan Africa. The people who have died from it have been
overwhelmingly Black Africans. The people most consistently denied the tools to
fight it — licensed vaccines, effective therapeutics, functioning health
infrastructure, and sustained international funding — have been Black Africans.
And the speed and scale of international response has historically increased
substantially when outbreaks have appeared to threaten Western citizens and health
systems directly.
During the 2014 to 2016 epidemic, global response
remained inadequate through the deaths of thousands of Africans. International
media coverage, political attention, and emergency funding increased markedly
when Western healthcare workers and citizens became infected and returned to
Europe and the United States. The pattern was observed and documented at the
time.
This is not a pattern unique to Ebola. A 2025
analysis published in the New England Journal of Medicine, examining a decade
of disparities in Ebola response, cited evidence that the political economy of
global health is structured to improve and lengthen the lives of those in the
Global North while neglecting and shortening the lives of those in the Global
South. It noted that breakthrough treatments for Ebola virus disease were
developed but remained largely inaccessible in the communities that most needed
them.
The
Vaccine Development Gap
The Bundibugyo strain responsible for the active
2026 outbreak has no approved vaccine and no specific therapeutic. The Zaire
ebolavirus strain, which caused the largest outbreaks in history, does have an
approved vaccine. That vaccine was developed in significant part because the
prospect of Zaire ebolavirus reaching major Western cities generated political
will and emergency funding that years of African deaths from the same disease
family had not produced.
Partners in Health, reflecting on the pattern of
COVID-19 vaccine distribution, described wealthy nations securing global supply
and leaving African countries to access what remained, while simultaneously
imposing travel restrictions on African countries and blaming them for low
vaccination rates. The same researchers described this as cynical and rooted in
the same structural logic that has governed access to Ebola countermeasures.
The pattern of differential access across HIV, COVID-19, mpox, and Ebola reflects
a consistent structural reality rather than a series of isolated policy
failures.
The 2026 outbreak has been directly worsened by the
2025 cuts to US CDC operations in Africa and the dismantling of USAID's
overseas health programmes, eliminating expertise, infrastructure, and
relationships that had been built over years to enable exactly this kind of
emergency response.
A
Precise and Evidenced Conclusion
To argue that Ebola has often been treated by the
global health system as a crisis that becomes urgent only when it threatens to
move beyond Black African populations is not to allege conscious individual
malice. It is to describe a documented pattern in which research investment,
vaccine development priorities, funding decisions, and international response
speed have consistently favoured outcomes for wealthier, predominantly white
populations over those of sub-Saharan Africa.
Whether that pattern derives from explicit racial
bias, structural economic inequality, political economy, institutional inertia,
or some combination of all these factors, its consequences for Black African
communities have been the same: inadequate tools, delayed responses, and
preventable deaths. Addressing this pattern requires naming it accurately,
analysing it rigorously, and changing the funding and governance arrangements
that reproduce it.
The lives lost in Ituri Province, North Kivu and
Kampala in 2026 must be treated with the same urgency, dignity and political
seriousness as lives threatened in Europe or North America. Every credible
framework for global health equity begins with that acknowledgement.
What
Must Change: A Framework for Ending the Cycle
Invest
in Health Systems, Not Just Emergency Response
The single most important structural change is a
sustained shift from reactive emergency funding to proactive health system
investment. Ebola outbreaks are controlled primarily through basic public
health infrastructure: laboratories that identify pathogens quickly, health
workers who trace contacts and isolate cases, roads that allow rapid deployment
of response teams, and communities with enough trust in the health system to
report symptoms early. These do not exist in adequate measure across eastern DRC
or in many other outbreak-prone areas.
Funding models that release resources only after an
emergency declaration guarantee that each outbreak will be larger than
necessary. Long-term investment in health worker training, laboratory networks,
surveillance systems, and community health programmes is not generosity. It is
the most cost-effective approach to preventing outbreaks from becoming
epidemics.
Develop
and Stockpile Vaccines for All Ebola Strains
The scientific community and international funders
must commit to accelerated vaccine development for all clinically significant
Ebola strains. The current situation, in which an approved vaccine exists only
for the Zaire strain, reflects research funding driven by market incentives and
geopolitical risk calculations rather than by public health need. Promising
Bundibugyo vaccine candidates exist. They require clinical trial infrastructure
built in genuine partnership with African institutions, not through the kind of
extractive research relationships that have historically characterised
international health research in Africa.
African scientists, community members, ethics
boards, and regulatory bodies must be full partners in research and development
— from study design through to data ownership and publication — not passive
subjects of externally directed trials.
Address
the Ecological and Environmental Drivers
No medical response will permanently interrupt
Ebola's cycle if the ecological conditions driving zoonotic spillover are not
addressed. Sustainable land management, alternative livelihoods that reduce
dependence on bushmeat hunting and forest encroachment, and wildlife
surveillance programmes capable of detecting novel spillover events early must
be integrated into African and international development frameworks.
Environmental health and human health are not separate domains.
Build
Trust Through Community Engagement
Effective Ebola response depends on communities
co-operating with it. Contact tracing works only when people disclose their
contacts. Isolation is effective only when people believe those they love will
receive dignified care. Safe burial protocols are followed only when
communities are engaged with genuine respect rather than directed from outside.
Sustained investment in community health workers,
drawn from the communities they serve and trusted by them, represents one of
the highest-return interventions available in outbreak prevention and control.
This is consistently well evidenced. It is also consistently underfunded
relative to the technical and clinical components of outbreak response.
What
Individuals Can Do
For communities in or near affected areas, the most
important protective steps are: avoiding direct contact with the blood or
bodily fluids of sick individuals; reporting symptoms early to a health
facility rather than waiting; supporting safe and dignified burials; protecting
healthcare workers by allowing them to work safely; not spreading
misinformation about the disease or its origins; and not stigmatising
survivors, who do not pose a risk through casual contact once they have
recovered and tested clear.
For international audiences, the most useful action
is supporting organisations working on sustained health system strengthening in
Africa rather than only emergency relief, and holding governments and donors
accountable for the equity of their global health spending.
Reform
the Financing Architecture of Global Health
African governments and institutions must increase
financial self-sufficiency in health emergency preparedness, as the Africa
CDC's leadership has acknowledged publicly. But this is only achievable if
international economic arrangements allow African countries to invest
domestically in health rather than transferring fiscal resources to external
creditors. Debt relief, fair trade terms, and equitable investment frameworks
are not peripheral to global health outcomes. They are central to them.
The structural dependency on donor funding that
leaves African health systems exposed to the domestic political decisions of
the United States, the United Kingdom, or Germany is itself the product of
global economic arrangements that have extracted value from the African
continent for generations. Greater African health sovereignty is not a request
for generosity. It is a condition for equity.
Conclusion
Ebola keeps coming back because the conditions that
allow it to spill from animal populations into human communities, and then to
move through under-resourced health systems faster than responses can contain
it, have not been structurally changed in fifty years. Dozens of expert panels,
internal reports, and peer-reviewed analyses have reached the same conclusions.
The knowledge of what needs to change is not missing. The sustained political
will and equitable funding to implement those changes consistently is what has
been absent.
The 2026 Bundibugyo outbreak in the Democratic
Republic of the Congo and Uganda is unfolding with no approved vaccine, a
response apparatus weakened by Western funding withdrawals, and in communities
simultaneously suffering from conflict, displacement, and food insecurity. None
of these conditions were inevitable. Each reflects policy choices made by
governments, institutions, and donors with the resources to have chosen
differently.
Ebola is not an African problem. It is a global
health failure concentrated in Africa, among people whose deaths have been
treated, for too long, as a regrettable but manageable reality by those with
the means to change the outcome. The science to understand it exists. The tools
to respond to it exist. What remains to be found is the political will and the
structural equity to deploy them without distinction, everywhere they are
needed.
Frequently
Asked Questions
How does Ebola spread from person to person?
Ebola spreads through direct contact with the
blood, bodily fluids, or organs of infected people. It does not spread through
the air under normal conditions, meaning it cannot be contracted by breathing
shared air or through casual contact such as sitting near an infected person.
Healthcare workers and family carers without proper protective equipment are at
highest risk. Safe burial practices are essential because the virus remains
active in the bodies of people who have died from the disease.
Why is there no Ebola vaccine for the Bundibugyo strain causing the 2026
outbreak?
Vaccine development priorities have historically
been driven by the perceived risk to wealthy nations and by research funding
availability. The Zaire ebolavirus strain received the most sustained
scientific investment because it caused the largest outbreaks. The Bundibugyo
strain, first identified in 2007, caused smaller outbreaks before 2026 and
attracted comparatively limited research funding. Promising Bundibugyo vaccine
candidates are under investigation, but none have been licensed. This reflects
a structural failure in global health research equity rather than a purely
scientific limitation.
Why does Ebola keep breaking out in the DRC?
The Democratic Republic of the Congo has
experienced seventeen Ebola outbreaks since 1976 for reasons that are
ecological, political, and economic simultaneously. Its forests contain the
animal reservoir of the virus. Its eastern provinces have experienced decades
of armed conflict that have prevented sustained health system development.
Health infrastructure remains deeply under-resourced. Communities in affected
areas have limited access to early diagnosis and treatment. And the conditions
driving human-animal contact, including deforestation, mining, and
poverty-related wildlife hunting, have not been adequately addressed.
What is the difference between the Ebola and Marburg viruses?
Both Ebola and Marburg are filoviruses that cause
severe haemorrhagic fever and are believed to originate in bat reservoir
species in Africa. However, they are caused by distinct viruses in different
genera. Marburg virus has a confirmed reservoir in the Egyptian fruit bat and
has caused outbreaks primarily in East and Central Africa. Ebola is caused by
Orthoebolavirus species with reservoir ecology that varies by strain and
remains incompletely understood. Both illustrate the same pattern: lethal viruses
circulating in African populations for decades without adequate vaccine
development or health infrastructure investment.
Is Ebola a risk outside Africa?
Ebola's primary risk is in the forested regions of
Central and West Africa where its animal reservoir exists. However, it can
spread internationally through travel, as occurred during the 2014 epidemic
when cases appeared in the United States and Europe, and as demonstrated in the
2026 outbreak when an infected traveller died in Kampala. Effective containment
in affected African regions remains the most reliable protection for all
populations globally. Contact tracing and border health monitoring reduce but
do not eliminate the risk of international transmission during active
outbreaks.
Has global health response to Ebola been shaped by racial inequality?
The evidence supports a careful and specific
answer. Documented patterns show that international funding, response urgency,
and vaccine development have consistently been slower and less generous when
outbreaks affect only African populations. The speed and scale of international
response in 2014 increased significantly when Western healthcare workers and
citizens were infected. Research and treatment investment in Ebola
countermeasures has followed similar patterns. The New England Journal of
Medicine and others have described the structure of global health as
systematically producing better outcomes for wealthier populations. This is a
pattern rooted in structural inequality rather than necessarily in deliberate
individual intent, but its consequences for African communities have been the
same.
What can prevent future Ebola outbreaks?
Prevention requires sustained, simultaneous action
across multiple domains: long-term investment in African health system
infrastructure rather than reactive emergency funding; accelerated and
equitable vaccine development for all Ebola strains; community engagement
programmes that build genuine trust rather than imposing external instructions;
ecological management strategies that reduce human-animal contact in forest
regions; wildlife surveillance to detect novel spillover events early; and
reform of international health financing so that African countries can fund
preparedness from their own budgets rather than depending on external donors
whose priorities can shift abruptly.
References
World
Health Organization (2026) Ebola disease caused by Bundibugyo virus: Democratic
Republic of the Congo and Uganda — Disease Outbreak News, 10 June 2026. Geneva:
WHO. Available at:
https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON607
World
Health Organization (2026) Ebola disease caused by Bundibugyo virus: DRC and
Uganda — Disease Outbreak News, 17 May 2026. Geneva: WHO. Available at:
https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON603
European
Centre for Disease Prevention and Control (2026) Ebola disease outbreak in the
Democratic Republic of the Congo and Uganda. Stockholm: ECDC. Available at:
https://www.ecdc.europa.eu/en/ebola-virus-disease-outbreak-democratic-republic-congo-and-uganda
[Updated 15 June 2026].
Zomahoun, D.L. et al. (2026) Notes from the Field: Outbreak of Ebola
Disease Caused by Bundibugyo Virus, Democratic Republic of the Congo and
Uganda, May 2026. Morbidity and Mortality Weekly Report, 5 June 2026. Available
at: https://www.cdc.gov/mmwr/volumes/75/wr/mm7522e3.htm
Centers for
Disease Control and Prevention (2026) History of Ebola Outbreaks. Atlanta: CDC.
Available at: https://www.cdc.gov/ebola/outbreaks/index.html [Accessed 15 June
2026].
Centers for
Disease Control and Prevention (2025) Predictive Model for Estimating Annual
Ebolavirus Spillover Potential. Emerging Infectious Diseases, 31(4). Available
at: https://wwwnc.cdc.gov/eid/article/31/4/24-1193_article
McCrone, J.T. et al. (2026) Evidence of latency reshapes our
understanding of Ebola virus reservoir dynamics. bioRxiv preprint, 2 April
2026. doi: 10.1101/2025.10.17.683141. Available at:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12632977/
Evans, A.
et al. (2025) Reducing transmission in multiple settings is required to
eliminate the risk of major Ebola outbreaks: a mathematical modelling study.
Journal of the Royal Society Interface, 22(224). doi: 10.1098/rsif.2024.0765
Gavin, M.
(2026) A New Ebola Outbreak Spreads Through Conflict and a Weak U.S. Response.
Council on Foreign Relations, 22 May 2026. Available at:
https://www.cfr.org/articles/a-new-ebola-outbreak-spreads-through-conflict-and-a-weak-u-s-response
United
Nations (2026) Ebola outbreak in Central Africa declared a Public Health
Emergency of International Concern. UN News, 17 May 2026. Available at:
https://news.un.org/en/story/2026/05/1167531
United
Nations (2026) Ebola outbreak in DRC collides with conflict and hunger, WHO
warns. UN News, May 2026. Available at:
https://news.un.org/en/story/2026/05/1167592
CNN (2026)
US funding cuts have hampered response to the deadly Ebola crisis, aid workers
say. CNN, 22 May 2026. Available at:
https://www.cnn.com/2026/05/22/africa/ebola-us-aid-cuts-drc-uganda-intl
Levine,
M.M. et al. (2025) Ebola and a Decade of Disparities: Forging a Future for
Global Health Equity. New England Journal of Medicine, 18 January 2025.
Available at: https://www.nejm.org/doi/full/10.1056/NEJMp2413298
Partners in
Health (2022) A Moral Failure: Global Vaccine Inequity Hits Africa Hardest.
Available at:
https://www.pih.org/article/moral-failure-global-vaccine-inequity-hits-africa-hardest
Africa
Centres for Disease Control and Prevention (2026) Joint continental
preparedness and response plan for Ebola disease caused by Bundibugyo virus.
Addis Ababa: Africa CDC. Launched 5 June 2026. Available at:
https://africacdc.org
Al Jazeera
(2014) WHO Faulted for Ebola Response Failures. Al Jazeera, 18 October 2014.
Available at:
https://www.aljazeera.com/amp/news/2014/10/18/who-faulted-for-ebola-response-failures
Comments
Post a Comment